BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/22/2021 9:56:11 AM | Browse: 605 | Download: 1690
 |
Received |
|
2021-03-13 16:11 |
|
Peer-Review Started |
|
2021-03-13 16:13 |
|
First Decision by Editorial Office Director |
|
2021-06-07 01:31 |
|
Return for Revision |
|
2021-06-07 01:31 |
|
Revised |
|
2021-06-25 16:57 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-09-08 03:03 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-09-08 18:58 |
|
Articles in Press |
|
2021-09-08 18:58 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-10-19 04:44 |
|
Publish the Manuscript Online |
|
2021-10-22 09:56 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
A biomarker study in Peruvian males with breast cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Carlos A Castaneda, Miluska Castillo, Luis A Bernabe, Joselyn Sanchez, Ebert Torres, Nancy Suarez, Katherine Tello, Hugo Fuentes, Jorge Dunstan, Miguel De La Cruz, Jose Manuel Cotrina, Julio Abugattas, Henry Guerra and Henry L Gomez |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica |
198-2015-FONDECYT |
|
| Corresponding Author |
Carlos A Castaneda, MD, MSc, Associate Research Scientist, Faculty of Health Sciences, Universidad Cientifica del Sur, Carr. Panamericana Sur 19, Villa El Salvador, Lima 15067, Peru. carloscastanedaaltamirano@yahoo.com |
| Key Words |
Male breast neoplasm; Androgen receptor; Tumor-infiltrating lymphocyte; Mismatch repair protein; PIK3CA mutation |
| Core Tip |
Most male breast cancers were estrogen receptor-positive, HER2-negative, androgen receptor (AR)-positive, and Luminal A phenotype. Loss of mismatch repair (MMR) and PIK3CA mutations was found in around 15% of the cases. AR was correlated with ER expression and without loss of MMR proteins. Stage and grade are prognostic features in Peruvian male breast cancer. |
| Publish Date |
2021-10-22 09:56 |
| Citation |
Castaneda CA, Castillo M, Bernabe LA, Sanchez J, Torres E, Suarez N, Tello K, Fuentes H, Dunstan J, De La Cruz M, Cotrina JM, Abugattas J, Guerra H, Gomez HL. A biomarker study in Peruvian males with breast cancer. World J Clin Oncol 2021; 12(10): 926-934 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i10/926.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i10.926 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
